Emerging temporal trends in tissue plasminogen activator use Results from the BASIC project

被引:14
作者
Domino, Joseph S. [1 ]
Baek, Jonggyu [1 ]
Meurer, William J. [2 ]
Garcia, Nelda [3 ]
Morgenstern, Lewis B. [1 ,3 ]
Campbell, Morgan
Lisabeth, Lynda D. [1 ,3 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Stroke Program, Ann Arbor, MI 48109 USA
关键词
BRAIN ATTACK SURVEILLANCE; ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; ETHNIC DISPARITIES; MEXICAN-AMERICANS; SEX-DIFFERENCES; CARE; OUTCOMES; DETERMINANTS; POPULATION;
D O I
10.1212/WNL.0000000000003349
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To explore temporal trends in tissue plasminogen activator (tPA) administration for acute ischemic stroke (AIS) in a biethnic community without an academic medical center and variation in trends by age, sex, ethnicity, and stroke severity. Methods: Cases of AIS were identified from 7 hospitals in the Brain Attack Surveillance in Corpus Christi (BASIC) project, a population-based surveillance study between January 1, 2000, and June 30, 2012. tPA, demographics, and stroke severity as assessed by the NIH Stroke Scale (NIHSS) were ascertained from medical records. Temporal trends were explored using generalized estimating equations, and adjustment made for age, sex, ethnicity, and NIHSS. Interaction terms were included to test for effect modification. Results: There were 5,277 AIS cases identified from 4,589 unique individuals. tPA use was steady at 2% and began increasing in 2006, reaching 11% in subsequent years. Stroke severity modified temporal trends (p = 0.003) such that cases in the highest severity quartile (NIHSS > 8) had larger increases in tPA use than those in lower severity quartiles. Although ethnicity did not modify the temporal trend, Mexican Americans (MAs) were less likely to receive tPA than non-Hispanic-whites (NHWs) due to emerging ethnic differences in later years. Conclusions: Dramatic increases in tPA use were apparent in this community without an academic medical center. Primary stroke center certification likely contributed to this rise. Results suggest that increases in tPA use were greater in higher severity patients compared to lower severity patients, and a gap between MAs and NHWs in tPA administration may be emerging.
引用
收藏
页码:2184 / 2191
页数:8
相关论文
共 39 条
  • [1] Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States A Doubling of Treatment Rates Over the Course of 5 Years
    Adeoye, Opeolu
    Hornung, Richard
    Khatri, Pooja
    Kleindorfer, Dawn
    [J]. STROKE, 2011, 42 (07) : 1952 - 1955
  • [2] Utilization of Intravenous Tissue Plasminogen Activator for Ischemic Stroke: Are There Sex Differences?
    Allen, Norrina B.
    Myers, Daniela
    Watanabe, Emi
    Dostal, Jackie
    Sama, Danny
    Goldstein, Larry B.
    Lichtman, Judith H.
    [J]. CEREBROVASCULAR DISEASES, 2009, 27 (03) : 254 - 258
  • [3] [Anonymous], TX CENS DAT
  • [4] [Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.cir.0000441139.02102.80
  • [5] ASPLUND K, 1988, ACTA MED SCAND, P26
  • [6] Older stroke patients in Europe: stroke care and determinants of outcome
    Bhalla, A
    Grieve, R
    Tilling, K
    Rudd, AG
    Wolfe, CDA
    [J]. AGE AND AGEING, 2004, 33 (06) : 618 - 624
  • [7] Resource utilization and outcome at a university versus a community teaching hospital in tPA treated stroke patients: a retrospective cohort study
    Caveney, Angela F.
    Silbergleit, Robert
    Frederiksen, Shirley
    Meurer, William J.
    Hickenbottom, Susan L.
    Smith, Rodney W.
    Scott, Phillip A.
    [J]. BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [8] Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421
  • [9] Racial-Ethnic Disparities in Stroke Care: The American Experience A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
    Cruz-Flores, Salvador
    Rabinstein, Alejandro
    Biller, Jose
    Elkind, Mitchell S. V.
    Griffith, Patrick
    Gorelick, Philip B.
    Howard, George
    Leira, Enrique C.
    Morgenstern, Lewis B.
    Ovbiagele, Bruce
    Peterson, Eric
    Rosamond, Wayne
    Trimble, Brian
    Valderrama, Amy L.
    [J]. STROKE, 2011, 42 (07) : 2091 - 2116
  • [10] IV tissue plasminogen activator use in acute stroke - Experience from a statewide registry
    Deng, YZ
    Reeves, MJ
    Jacobs, BS
    Birbeck, GL
    Kothari, RU
    Hickenbottom, SL
    Mullard, AJ
    Wehner, S
    Maddox, K
    Majid, A
    [J]. NEUROLOGY, 2006, 66 (03) : 306 - 312